Jennison Associates
KURA icon

Jennison Associates’s Kura Oncology KURA Stock Holding History

Jennison Associates’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-56,731
Closed -$502K – 613
2025
Q3 		$502K Sell
56,731
-85,931
-60% -$613K ﹤0.01% 539
2025
Q2 		$823K Buy
142,662
+4,130
+3% +$25.3K ﹤0.01% 506
2025
Q1 		$914K Buy
138,532
+67,035
+94% +$522K ﹤0.01% 486
2024
Q4 		$623K Buy
+71,497
New +$1.03M ﹤0.01% 540

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Jennison Associates's KURA Position: Q4 2025 in Review

Jennison Associates sold out of Kura Oncology (KURA) in Q4 2025, closing a stake of 56,731 shares — an estimated $502K sold.

Jennison Associates first reported a position in KURA in Q4 2024 and held it in 4 quarters. The position peaked at $914K in Q1 2025. 215 funds tracked by Wall St. Rank hold KURA as of Q4 2025.

  • Jennison Associates reported no remaining Kura Oncology position as of Q4 2025 after selling out during the quarter.
  • Jennison Associates sold 56,731 Kura Oncology shares in Q4 2025, an estimated $502K.
  • Jennison Associates first reported a position in Kura Oncology in Q4 2024 and held it in 4 quarters.
  • Jennison Associates's Kura Oncology position peaked at $914K in Q1 2025.
  • 215 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2025.

Based on Jennison Associates's 13F filing for Q4 2025, filed 30 Jan 2026.